Who invested in Aeovian Pharmaceuticals?
Aeovian Pharmaceuticals's investors include Foresite Capital, Apollo and B2venture.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$55Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $55M sold, first sale Nov 2025
From Aeovian Pharmaceuticals's own website: 5 on the team.
Aeovian Pharmaceuticals's investors include Foresite Capital, Apollo and B2venture.
Aeovian Pharmaceuticals has raised $55M across 1 round since 2025.
Aeovian Pharmaceuticals's most recent round was a Series B of $55M in Dec 2025.
Its most recent round, $55M in Dec 2025, is also its largest on record.
Aeovian Pharmaceuticals's first round on record, in Dec 2025, was backed by Foresite Capital, Apollo and B2venture.
Aeovian Pharmaceuticals's latest named round is a Series B, in Dec 2025.
Aeovian Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.